Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Real-world data on ivosidenib in patients with previously treated isocitrate dehydrogenase 1-mutated intrahepatic cholangiocarcinomas: an early exploratory analysis
M Rimini, V Burgio, L Antonuzzo, L Rimassa… - Targeted Oncology, 2022 - Springer
Background The results of the phase III ClarIDHy trial have led to US FDA approval of
ivosidenib as a therapeutic option for patients with locally advanced or metastatic …
ivosidenib as a therapeutic option for patients with locally advanced or metastatic …
Sustained Clinical Response to Ivosidenib in Previously Treated Patients with Advanced Intrahepatic Cholangiocarcinoma Harboring an IDH1 R132 Mutation: Two …
C Müller, S Franke, T Reisländer, V Keitel… - Case Reports in …, 2024 - karger.com
Introduction: Patients with progressing intrahepatic cholangiocarcinoma (iCCA) harboring
an isocitrate dehydrogenase 1 (IDH1) mutation who received ivosidenib showed a median …
an isocitrate dehydrogenase 1 (IDH1) mutation who received ivosidenib showed a median …